Kamari Pharma
Latest round
- Series A
Last raised
- Jun 2025
Total raised
- $23M
Investors
- 2
About Kamari Pharma
Based in Israel, and founded in 2018, Kamari Pharma Ltd. operates as a developer of topical and oral drugs for treating skin diseases. In June 2025, Kamari Pharma Ltd. The company develops topical and oral medications based on patented small peptides that disrupt an ion channel TRPV3. These medications are designed to treat a variety of dermatological conditions, including keratoderma, Olmsted syndrome, pruritus, atopic dermatitis, ichthyosis, lichen simplex chronicus, and other severe inherited skin problems.
Who invested in Kamari Pharma
2 investors across 1 round
See all investors in Kamari Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 3, 2025
Amount
$23M
Investors
Questions about Kamari Pharma
Who invested in Kamari Pharma?
Kamari Pharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kamari Pharma raised?
Kamari Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kamari Pharma last raise money?
Kamari Pharma's most recent round on record is a Series A, in Jun 2025.
What does Kamari Pharma do?
Based in Israel, and founded in 2018, Kamari Pharma Ltd.
Where is Kamari Pharma headquartered?
Kamari Pharma is headquartered in Ness Ziona, Israel.
Which VCs invest in companies like Kamari Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Kamari Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kamari Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.